2-Deoxy-L-ribose inhibits the invasion of thymidine phosphorylase-overexpressing tumors by suppressing matrix metalloproteinase-9
- PMID: 16646076
- DOI: 10.1002/ijc.22014
2-Deoxy-L-ribose inhibits the invasion of thymidine phosphorylase-overexpressing tumors by suppressing matrix metalloproteinase-9
Abstract
Thymidine phosphorylase (TP), an enzyme involved in pyrimidine metabolism, is identical with an angiogenic factor, platelet-derived endothelial cell growth factor. 2-Deoxy-D-ribose (D-dRib), the degradation product of thymidine generated by TP activity, has been suggested to be a downstream mediator of TP function. 2-Deoxy-L-ribose (L-dRib), a stereoisomer of D-dRib, inhibited the promotion of angiogenesis, tumor growth and metastasis by TP. In our study, we have shown that nude mice inoculated with TP-overexpressing KB/TP cells had shorter survival times than those injected with control KB/CV cells. KB/TP tumors were also more highly invasive than KB/CV tumors in mice. The expression levels of matrix metalloproteinase (MMP)-9 in KB/TP tumors were significantly higher than those in KB/CV tumors. L-dRib and a TP inhibitior, TPI, extended the survival period of KB/TP tumor-bearing mice. L-dRib also reduced MMP-9 mRNA levels in KB/TP tumors. Furthermore, L-dRib suppressed the mRNA level of MMP-9 in cultured KB/TP cells, and the invasive activity of the cells. L-dRib may be useful for the suppression of invasion of TP-expressing tumor cells.
Copyright 2006 Wiley-Liss, Inc.
Similar articles
-
Inhibition of metastasis of tumor cells overexpressing thymidine phosphorylase by 2-deoxy-L-ribose.Cancer Res. 2004 Mar 1;64(5):1794-801. doi: 10.1158/0008-5472.can-03-2597. Cancer Res. 2004. PMID: 14996742
-
Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-ribose.Cancer Res. 2002 May 15;62(10):2834-9. Cancer Res. 2002. PMID: 12019161
-
2-Deoxy-D-ribose, a downstream mediator of thymidine phosphorylase, regulates tumor angiogenesis and progression.Anticancer Agents Med Chem. 2009 Feb;9(2):239-45. doi: 10.2174/187152009787313846. Anticancer Agents Med Chem. 2009. PMID: 19199868 Review.
-
Blockage of 2-deoxy-D-ribose-induced angiogenesis with rapamycin counteracts a thymidine phosphorylase-based escape mechanism available for colon cancer under 5-fluorouracil therapy.Clin Cancer Res. 2004 Mar 1;10(5):1843-52. doi: 10.1158/1078-0432.ccr-1176-3. Clin Cancer Res. 2004. PMID: 15014039
-
The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression.Cancer Sci. 2004 Nov;95(11):851-7. doi: 10.1111/j.1349-7006.2004.tb02193.x. Cancer Sci. 2004. PMID: 15546501 Free PMC article. Review.
Cited by
-
Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors.Br J Cancer. 2011 Mar 29;104(7):1185-92. doi: 10.1038/bjc.2011.74. Epub 2011 Mar 8. Br J Cancer. 2011. PMID: 21386840 Free PMC article.
-
Identification of predictive circulating biomarkers of bevacizumab-containing regimen efficacy in pre-treated metastatic colorectal cancer patients.Br J Cancer. 2012 Jul 10;107(2):287-90. doi: 10.1038/bjc.2012.242. Epub 2012 Jun 14. Br J Cancer. 2012. PMID: 22699823 Free PMC article.
-
Effects of thymidine phosphorylase on tumor aggressiveness and 5-fluorouracil sensitivity in cholangiocarcinoma.World J Gastroenterol. 2010 Apr 7;16(13):1631-8. doi: 10.3748/wjg.v16.i13.1631. World J Gastroenterol. 2010. PMID: 20355241 Free PMC article.
-
The dual role of thymidine phosphorylase in cancer development and chemotherapy.Med Res Rev. 2009 Nov;29(6):903-53. doi: 10.1002/med.20159. Med Res Rev. 2009. PMID: 19434693 Free PMC article. Review.
-
Thymidine phosphorylase promotes metastasis and serves as a marker of poor prognosis in hepatocellular carcinoma.Lab Invest. 2017 Aug;97(8):903-912. doi: 10.1038/labinvest.2017.51. Epub 2017 May 22. Lab Invest. 2017. PMID: 28530649
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous